Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07 Janvier 2025 - 10:05PM
Business Wire
Bruker Corporation (Nasdaq: BRKR) announced today it will
participate in the 43rd annual J.P. Morgan Healthcare Conference in
San Francisco. Frank Laukien, Chairman, President & CEO, Mark
Munch, Executive Vice President & President of Bruker Nano
Group, and Gerald Herman, Executive Vice President & CFO will
present on behalf of the Company on Monday, January 13th, 2025 at
3:45 PM Pacific Standard Time.
A live audio webcast of the presentation will be available on
the Investor Relations section of the Company's website at
https://ir.bruker.com. A replay of the presentation will be posted
in the “Events & Presentations” section of the Bruker
Corporation Investor Relations website after the event and will be
available for 30 days following the presentation.
About Bruker Corporation – Leader of the Post-Genomic Era
(Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough
post-genomic discoveries and develop new applications that improve
the quality of human life. Bruker’s high performance scientific
instruments and high value analytical and diagnostic solutions
enable scientists to explore life and materials at molecular,
cellular, and microscopic levels. In close cooperation with our
customers, Bruker is enabling innovation, improved productivity,
and customer success in post-genomic life science molecular and
cell biology research, in applied and biopharma applications, in
microscopy and nanoanalysis, as well as in industrial and cleantech
research, and next-gen semiconductor metrology in support of AI.
Bruker offers differentiated, high value life science and
diagnostics systems and solutions in preclinical imaging, clinical
phenomics research, proteomics and multiomics, spatial and
single-cell biology, functional structural and condensate biology,
as well as in clinical microbiology and molecular diagnostics. For
more information, please visit www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250107351795/en/
Joe Kostka Director, Investor Relations Bruker Corporation T: +1
(978) 313-5800 E: Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Bruker (NASDAQ:BRKR)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025